Adma Biologics Inc (ADMA) - News Archive

Showing 3 of 3 results.

Navigating Double Currents ADMA Biologics Financial Gains and Legal Scrutiny,

Investigation of ADMA Biologics Underway Amidst Company’s Financial Milestones In recent developments, ADMA Biologics Inc. a biopharmaceutical company headquartered in New Jersey and listed on NASDAQ under the ticker AD...

Oct 15, 2024 • Biotechnology & Pharmaceuticals Industry Announcement Class ActionS The Mad Money Lightning Round Jim Cr

ADMA Biologics Makes Headway in Debt Reduction and Financial Performance Amidst Recent Challenges,

ADMA Biologics Announces Partial Paydown of Revolving Credit FacilityIn a recent press release, ADMA Biologics Inc announced that it has utilized its cash on hand to partially pay down its revolving credit facility with...

Aug 14, 2024 • Biotechnology & Pharmaceuticals Industry Management Announcement

ADMA Biologics Secures $135 Million Non-Dilutive Financing, Setting the Stage for Future Growth and Financial Stability

ADMA Biologics Secures $135 Million Non-Dilutive Refinancing Deal with Ares Management, Consolidating Debt and Bolstering Financial StabilityIn a major move to strengthen its financial position, ADMA Biologics, a biopha...

Dec 18, 2023 • Biotechnology & Pharmaceuticals Industry Financing Agreement